172 related articles for article (PubMed ID: 20103601)
1. Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.
Guenterberg KD; Grignol VP; Raig ET; Zimmerer JM; Chan AN; Blaskovits FM; Young GS; Nuovo GJ; Mundy BL; Lesinski GB; Carson WE
Mol Cancer Ther; 2010 Feb; 9(2):510-20. PubMed ID: 20103601
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
Benhassine M; Le-Bel G; Guérin SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
Zheng M; Bocangel D; Ramesh R; Ekmekcioglu S; Poindexter N; Grimm EA; Chada S
Mol Cancer Ther; 2008 Dec; 7(12):3842-51. PubMed ID: 19056673
[TBL] [Abstract][Full Text] [Related]
4. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
5. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
[TBL] [Abstract][Full Text] [Related]
6. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ
J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cells.
Lesinski GB; Benninger K; Kreiner M; Quimper M; Young G; Carson WE
Cancer Immunol Immunother; 2009 Dec; 58(12):2031-7. PubMed ID: 19396596
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and Interferon-α Signaling
Danziger O; Pupko T; Bacharach E; Ehrlich M
Front Immunol; 2018; 9():94. PubMed ID: 29441069
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-24 in the tumor-suppressive effects of interferon-β on melanoma.
Watanabe Y; Itoh M; Nakagawa H; Asahina A; Nobeyama Y
Exp Dermatol; 2019 Jul; 28(7):836-844. PubMed ID: 31070806
[TBL] [Abstract][Full Text] [Related]
10. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.
Maher SG; Sheikh F; Scarzello AJ; Romero-Weaver AL; Baker DP; Donnelly RP; Gamero AM
Cancer Biol Ther; 2008 Jul; 7(7):1109-15. PubMed ID: 18698163
[TBL] [Abstract][Full Text] [Related]
11. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
12. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells.
de Totero D; Capaia M; Fabbi M; Croce M; Meazza R; Cutrona G; Zupo S; Loiacono F; Truini M; Ferrarini M; Ferrini S
Exp Hematol; 2010 May; 38(5):373-83. PubMed ID: 20193734
[TBL] [Abstract][Full Text] [Related]
14. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
15. IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.
Deng WG; Kwon J; Ekmekcioglu S; Poindexter NJ; Grimm EA
Melanoma Res; 2011 Feb; 21(1):44-56. PubMed ID: 20216471
[TBL] [Abstract][Full Text] [Related]
16. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
17. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes.
Zhang SQ; Zhang Z; Luo X; Yang S; Chai Y; Huang HL; Yin XY; Hu DJ; Yang CJ; Liu JL; Zhang XJ
Inflamm Res; 2011 Nov; 60(11):1031-7. PubMed ID: 21847628
[TBL] [Abstract][Full Text] [Related]
19. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells.
Selvi N; Kaymaz BT; Gündüz C; Aktan C; Kiper HD; Sahin F; Cömert M; Selvi AF; Kosova B; Saydam G
Tumour Biol; 2014 Aug; 35(8):7861-70. PubMed ID: 24824872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
